Fact CheckerSign in

NCT06729203Recruiting

Effect of Ultrasound Cavitation on Insulin Resistance in Patients with Central Obesity in Female

Source: ClinicalTrials.gov · Last updated 11 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this study was to investigate the effect of ultrasound cavitation on insulin resistance, HbA1c and skin fold in patients with abdominal central obesity.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
52 (estimated)
First submitted
8 Dec 2024
Start date
1 Dec 2024
Primary completion date
1 Feb 2025
Lead sponsor
Cairo University
Diseases
Obesity
NCT number
NCT06729203

What you commit to

  • Study type: Interventional
  • Planned participants: 52
  • From 1 Dec 2024 to the primary completion date, 1 Feb 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Lab values

  • • Subjects diagnosed with DM (HbA1c more than 6.5%).
    • History of metabolic disorders such as type 1 diabetes or thyroid disorders.
    • Subjects with BMI less than 30 kg/m2.
    • Subjects diagnosed with heart disease, liver as well as kidney diseases.
    • Subjects who take oral contraceptives.
    • Subjects with gestational Diabetes.
    • Pregnant or breastfeeding women were excluded from the study.
    • Use of weight-loss medications or supplements within the past six months.
    • Previous surgical procedures for weight loss or body contouring.
    • Contraindications to ultrasound therapy (e.g., metal implants in the abdomen, active skin infections).
    • Participation in another clinical trial within the last three months.

Who the study is looking for

  • Female subjects with central obesity.
  • Female participants aged between 25 to 40 years.
  • Body Mass Index (BMI) ranged from 30 to 35 kg/m2 as high BMI indicates more obesity and central obesity.
  • Waist circumference greater than 88 cm, indicative of abdominal obesity.
  • Diagnosed with insulin resistance (HOMA-IR \> 2.9).
  • Sedentary lifestyle, defined as engaging in less than 150 minutes of moderate-intensity physical activity per week.
  • Willingness to provide informed consent and comply with study procedures.

Age in the registry: 25 years to 40 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cairo University
Coordinator of this site? Confirm its status
GizaEgyptRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.